Literature DB >> 28324104

Vasoprotective Activities of the Adrenomedullin-RAMP2 System in Endothelial Cells.

Xian Xian1,2, Takayuki Sakurai1, Akiko Kamiyoshi1, Yuka Ichikawa-Shindo1, Megumu Tanaka1, Teruhide Koyama1, Hisaka Kawate1, Lei Yang3, Tian Liu1, Akira Imai1, Liuyu Zhai1, Kazutaka Hirabayashi1, Kun Dai1, Keiya Tanimura1, Teng Liu1, Nanqi Cui1, Kyoko Igarashi4, Akihiro Yamauchi4, Takayuki Shindo1.   

Abstract

Neointimal hyperplasia is the primary lesion underlying atherosclerosis and restenosis after coronary intervention. We previously described the essential angiogenic function of the adrenomedullin (AM)-receptor activity-modifying protein (RAMP) 2 system. In the present study, we assessed the vasoprotective actions of the endogenous AM-RAMP2 system using a wire-induced vascular injury model. We found that neointima formation and vascular smooth muscle cell proliferation were enhanced in RAMP2+/- male mice. The injured vessels from RAMP2+/- mice showed greater macrophage infiltration, inflammatory cytokine expression, and oxidative stress than vessels from wild-type mice and less re-endothelialization. After endothelial cell-specific RAMP2 deletion in drug-inducible endothelial cell-specific RAMP2-/- (DI-E-RAMP2-/-) male mice, we observed markedly greater neointima formation than in control mice. In addition, neointima formation after vessel injury was enhanced in mice receiving bone marrow transplants from RAMP2+/- or DI-E-RAMP2-/- mice, indicating that bone marrow-derived cells contributed to the enhanced neointima formation. Finally, we found that the AM-RAMP2 system augmented proliferation and migration of endothelial progenitor cells. These results demonstrate that the AM-RAMP2 system exerts crucial vasoprotective effects after vascular injury and could be a therapeutic target for the treatment of vascular diseases.
Copyright © 2017 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28324104     DOI: 10.1210/en.2016-1531

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Adrenomedullin Improves Cardiac Remodeling and Function in Obese Rats with Hypertension.

Authors:  Pei Qian; Qian Wang; Fang-Zheng Wang; Hang-Bing Dai; Hong-Yu Wang; Qing Gao; Hong Zhou; Ye-Bo Zhou
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-06

Review 2.  Receptor Activity Modifying Protein RAMP Sub-Isoforms and Their Functional Differentiation, Which Regulates Functional Diversity of Adrenomedullin.

Authors:  Takayuki Shindo; Megumu Tanaka; Akiko Kamiyoshi; Yuka Ichikawa-Shindo; Hisaka Kawate; Takayuki Sakurai
Journal:  Biology (Basel)       Date:  2022-05-21

3.  Structure and Dynamics of Adrenomedullin Receptors AM1 and AM2 Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying Proteins.

Authors:  Yi-Lynn Liang; Matthew J Belousoff; Madeleine M Fletcher; Xin Zhang; Maryam Khoshouei; Giuseppe Deganutti; Cassandra Koole; Sebastian G B Furness; Laurence J Miller; Debbie L Hay; Arthur Christopoulos; Christopher A Reynolds; Radostin Danev; Denise Wootten; Patrick M Sexton
Journal:  ACS Pharmacol Transl Sci       Date:  2020-03-20

4.  Adrenomedullin alleviates the pyroptosis of Leydig cells by promoting autophagy via the ROS-AMPK-mTOR axis.

Authors:  Ming-Yong Li; Xia-Lian Zhu; Bi-Xia Zhao; Lei Shi; Wei Wang; Wei Hu; Song-Lin Qin; Bing-Hai Chen; Pang-Hu Zhou; Bo Qiu; Yong Gao; Bo-Long Liu
Journal:  Cell Death Dis       Date:  2019-06-20       Impact factor: 8.469

5.  Mid-regional pro-adrenomedullin is a novel biomarker for arterial stiffness as the criterion for vascular failure in a cross-sectional study.

Authors:  Teruhide Koyama; Nagato Kuriyama; Yosuke Suzuki; Satoshi Saito; Ryota Tanaka; Motoshi Iwao; Megumu Tanaka; Takakuni Maki; Hiroki Itoh; Masafumi Ihara; Takayuki Shindo; Ritei Uehara
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

6.  Lymphatic endothelial-cell expressed ACKR3 is dispensable for postnatal lymphangiogenesis and lymphatic drainage function in mice.

Authors:  Elena C Sigmund; Lilian Baur; Philipp Schineis; Jorge Arasa; Victor Collado-Diaz; Martina Vranova; Rolf A K Stahl; Marcus Thelen; Cornelia Halin
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

7.  CRIF1 deficiency suppresses endothelial cell migration via upregulation of RhoGDI2.

Authors:  Harsha Nagar; Seonhee Kim; Ikjun Lee; Su-Jeong Choi; Shuyu Piao; Byeong Hwa Jeon; Minho Shong; Cuk-Seong Kim
Journal:  PLoS One       Date:  2021-08-26       Impact factor: 3.240

Review 8.  Endogenous Vasoactive Peptides and Vascular Aging-Related Diseases.

Authors:  Yao Chen; Yongfen Qi; Weiwei Lu
Journal:  Oxid Med Cell Longev       Date:  2022-10-03       Impact factor: 7.310

9.  Genetic Variants of RAMP2 and CLR are Associated with Stroke.

Authors:  Teruhide Koyama; Nagato Kuriyama; Etsuko Ozaki; Daisuke Matsui; Isao Watanabe; Wakiko Takeshita; Komei Iwai; Yoshiyuki Watanabe; Masahiro Nakatochi; Chisato Shimanoe; Keitaro Tanaka; Isao Oze; Hidemi Ito; Hirokazu Uemura; Sakurako Katsuura-Kamano; Rie Ibusuki; Ippei Shimoshikiryo; Naoyuki Takashima; Aya Kadota; Sayo Kawai; Tae Sasakabe; Rieko Okada; Asahi Hishida; Mariko Naito; Kiyonori Kuriki; Kaori Endoh; Norihiro Furusyo; Hiroaki Ikezaki; Sadao Suzuki; Akihiro Hosono; Haruo Mikami; Yohko Nakamura; Michiaki Kubo; Kenji Wakai
Journal:  J Atheroscler Thromb       Date:  2017-09-14       Impact factor: 4.928

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.